{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:53:02Z","timestamp":1790139182302,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1229,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ajpath.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T01:38:35Z","timestamp":1466127515000},"page":"2171-2182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Effects of IL-8 Up-Regulation on Cell Survival and Osteoclastogenesis in Multiple Myeloma"],"prefix":"10.1016","volume":"186","author":[{"given":"Ana B.","family":"Herrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Garc\u00eda-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Garayoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Corchete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma C.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2016.04.003_bib1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0268-960X(10)70003-5","article-title":"Multiple myeloma: biology of the disease","volume":"24","author":"Mahindra","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.ajpath.2016.04.003_bib2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ejca.2005.11.039","article-title":"Conventional diagnostics in multiple myeloma","volume":"42","author":"San Miguel","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2016.04.003_bib3","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib4","first-page":"597","article-title":"The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone","volume":"26","author":"Grigorieva","year":"1998","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2012-01-379024","article-title":"Myeloma as a model for the process of metastasis: implications for therapy","volume":"120","author":"Ghobrial","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V73.2.517.517","article-title":"Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6","volume":"73","author":"Klein","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib7","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","article-title":"Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma","volume":"95","author":"Dankbar","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib8","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/sj.leu.2402295","article-title":"Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications","volume":"15","author":"Gupta","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2016.04.003_bib9","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1038\/sj.onc.1204833","article-title":"Biologic sequelae of interleukin-6 induced PI3-K\/Akt signaling in multiple myeloma","volume":"20","author":"Hideshima","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2016.04.003_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B","volume":"87","author":"Chauhan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2249.1998.00711.x","article-title":"Fas\/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells","volume":"114","author":"Frassanito","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib12","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V84.9.3063.3063","article-title":"Interleukin-6 prevents dexamethasone-induced myeloma cell death","volume":"84","author":"Hardin","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/cimm.1995.1076","article-title":"Interleukin-6 inhibits apoptosis of malignant plasma cells","volume":"162","author":"Lichtenstein","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib14","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1073\/pnas.84.24.9233","article-title":"Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines","volume":"84","author":"Yoshimura","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2016.04.003_bib15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<937::AID-IJC3>3.0.CO;2-Q","article-title":"Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours","volume":"72","author":"Green","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2016.04.003_bib16","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jnci\/90.6.447","article-title":"Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice","volume":"90","author":"Yoneda","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2016.04.003_bib18","first-page":"5571","article-title":"Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in\u00a0vivo","volume":"62","author":"Bendre","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.neo.7900124","article-title":"Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice","volume":"3","author":"Kim","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.ajpath.2016.04.003_bib20","first-page":"93","article-title":"Expression of interleukin-8 correlates with vascularity in human gastric carcinomas","volume":"152","author":"Kitadai","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib21","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2016.04.003_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2016.04.003_bib23","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2249.1993.tb05943.x","article-title":"Cytokines involved in the progression of multiple myeloma","volume":"92","author":"Merico","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2141.2005.05443.x","article-title":"Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells","volume":"129","author":"Pellegrino","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.leukres.2006.06.012","article-title":"Cytokine and chemokine profiles in multiple myeloma: significance of stromal interaction and correlation of IL-8 production with disease progression","volume":"31","author":"Kline","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","article-title":"Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase","volume":"120","author":"Mihara","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1078-0432.CCR-13-1657","article-title":"Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease","volume":"20","author":"Garcia-Gomez","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3324\/haematol.2013.087809","article-title":"Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies","volume":"99","author":"Lopez-Corral","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ajpath.2016.04.003_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0092-8674(00)81731-6","article-title":"Tumor induction of VEGF promoter activity in stromal cells","volume":"94","author":"Fukumura","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2016.04.003_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/bbrc.1997.7156","article-title":"Induction of osteogenic differentiation by hedgehog proteins","volume":"237","author":"Nakamura","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2016.04.003_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.2000.01845.x","article-title":"Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts","volume":"108","author":"Karadag","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib33","doi-asserted-by":"crossref","first-page":"16639","DOI":"10.1074\/jbc.M200360200","article-title":"NF-kappa B as a therapeutic target in multiple myeloma","volume":"277","author":"Hideshima","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2016.04.003_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002620050605","article-title":"Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism","volume":"49","author":"Collins","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ajpath.2016.04.003_bib35","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/sj.onc.1209498","article-title":"Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2016.04.003_bib36","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/bjc.2013.186","article-title":"Paradoxical effect of lenalidomide on cytokine\/growth factor profiles in multiple myeloma","volume":"108","author":"Maiga","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2016.04.003_bib37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.4161\/cc.8.10.8415","article-title":"Targeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitors","volume":"8","author":"Gasparian","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ajpath.2016.04.003_bib38","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood-2002-01-0151","article-title":"Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells","volume":"100","author":"Mori","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/cyto.1999.0518","article-title":"Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in\u00a0vitro","volume":"12","author":"Brew","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.ajpath.2016.04.003_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10456-005-5208-4","article-title":"Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis","volume":"8","author":"Li","year":"2005","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ajpath.2016.04.003_bib41","first-page":"1405","article-title":"Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431","volume":"6","author":"Metzner","year":"1999","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajpath.2016.04.003_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002620050503","article-title":"Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells","volume":"47","author":"Miyamoto","year":"1998","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ajpath.2016.04.003_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fon.09.128","article-title":"CXCL8 and its cognate receptors in melanoma progression and metastasis","volume":"6","author":"Singh","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006676-200007000-00051","article-title":"Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1","volume":"21","author":"Takamori","year":"2000","journal-title":"Pancreas"},{"key":"10.1016\/j.ajpath.2016.04.003_bib45","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood-2003-02-0402","article-title":"Identification of genes modulated in multiple myeloma using genetically identical twin samples","volume":"103","author":"Munshi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib46","first-page":"269","article-title":"The angiogenic factor interleukin 8 is induced in non-small cell lung cancer\/pulmonary fibroblast cocultures","volume":"60","author":"Anderson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib47","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1074\/jbc.M113.502641","article-title":"Proteasome inhibition increases recruitment of IkappaB kinase beta (IKKbeta), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells","volume":"289","author":"Singha","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2016.04.003_bib48","first-page":"2327","article-title":"Activation of interleukin-6 gene expression through the NF-kappa B transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2741\/1579","article-title":"The role of interleukin-8 in cancer cells and microenvironment interaction","volume":"10","author":"Yuan","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.ajpath.2016.04.003_bib50","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.leukres.2007.11.015","article-title":"Alkylating agents induce activation of NFkappaB in multiple myeloma cells","volume":"32","author":"Baumann","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib51","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","article-title":"Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells","volume":"114","author":"Hideshima","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.04.003_bib52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1189\/jlb.72.5.847","article-title":"Multiple control of interleukin-8 gene expression","volume":"72","author":"Hoffmann","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2016.04.003_bib53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbrc.2015.03.041","article-title":"Anticancer drug bortezomib increases interleukin-8 expression in human monocytes","volume":"460","author":"Sanacora","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2016.04.003_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0169-328X(00)00074-7","article-title":"Serum-free induced neuronal apoptosis-like cell death is independent of caspase activity","volume":"78","author":"Hamabe","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.ajpath.2016.04.003_bib55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/35069004","article-title":"Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death","volume":"410","author":"Joza","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2016.04.003_bib56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.onc.1210679","article-title":"A pivotal role for Mcl-1 in Bortezomib-induced apoptosis","volume":"27","author":"Podar","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2016.04.003_bib57","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1038\/sj.onc.1208949","article-title":"Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1\/Bim complex","volume":"24","author":"Gomez-Bougie","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2016.04.003_bib58","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.4081\/ejh.2011.e21","article-title":"Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients","volume":"55","author":"Tsirakis","year":"2011","journal-title":"Eur J Histochem"},{"key":"10.1016\/j.ajpath.2016.04.003_bib59","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cyto.2011.08.034","article-title":"Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma","volume":"56","author":"Pappa","year":"2011","journal-title":"Cytokine"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016301134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016301134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:47:12Z","timestamp":1757602032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944016301134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0002944016301134"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.04.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of IL-8 Up-Regulation on Cell Survival and Osteoclastogenesis in Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}